Osteopontin regulates interleukin-17 production in hepatitis

Cytokine

Volumn 60, Issue 1, 2012, Pages 129-137

  Diao, Hongyan ^a   Liu, Xiangdong ^b   Wu, Zhongwen ^a   Kang, Lei ^a   Cui, Guangying ^a   Morimoto, Junko ^c   Denhardt, David T ^d   Rittling, Susan ^e   Iwakura, Yoichiro ^f   Uede, Toshimitsu ^c   Li, Lanjuan ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b ZHEJIANG SCI TECH UNIVERSITY   (China)

^c HOKKAIDO UNIVERSITY   (Japan)

^d RUTGERS UNIVERSITY   (United States)

^e FORSYTH INSTITUTE   (United States)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chronic hepatitis b; Concanavalin A induced hepatitis; IL 17; Osteopontin

Indexed keywords

BETA3 INTEGRIN; CONCANAVALIN A; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE P38; OSTEOPONTIN; STRESS ACTIVATED PROTEIN KINASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS; HEPATITIS B; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN CELL;

ADULT; ANIMALS; CELLS, CULTURED; CONCANAVALIN A; DRUG RESISTANCE; DRUG-INDUCED LIVER INJURY; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INTERLEUKIN-17; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKOCYTES, MONONUCLEAR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; OSTEOPONTIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDES; SIGNAL TRANSDUCTION; YOUNG ADULT;

MUS;

EID: 84865402716     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.287     Document Type: Article

References (40)

1. Lok A.S. The maze of treatments for hepatitis B. N Engl J Med 2005, 352(26):2743-2746.
2. Kagi D., Ledermann B., Burki K., Zinkernagel R.M., Hengartner H. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annu Rev Immunol 1996, 14:207-232.
3. Vierling J.M. The immunology of hepatitis B. Clin Liver Dis 2007, 11(4):727-759. [vii-viii].
4. Klein J., Sato A. The HLA system. First of two parts. N Engl J Med 2000, 343(10):702-709.
5. Klein J., Sato A. The HLA system. Second of two parts. N Engl J Med 2000, 343(11):782-786.
6. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28(4):454-467.
7. Langrish C.L., Chen Y., Blumenschein W.M., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201(2):233-240.
8. Zhang B., Rong G., Wei H., et al. The prevalence of Th17 cells in patients with gastric cancer. Biochem Biophys Res Commun 2008, 374(3):533-537.
9. Lemmers A., Moreno C., Gustot T., et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology (Baltimore, Md) 2009, 49(2):646-657.
10. Zhang J.Y., Zhang Z., Lin F., et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010, 51(1):81-91.
11. Ge J., Wang K., Meng Q.H., Qi Z.X., Meng F.L., Fan Y.C. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 2010, 30(1):60-67.
12. Tiegs G. Cellular and cytokine-mediated mechanisms of inflammation and its modulation in immune-mediated liver injury. Z Gastroenterol 2007, 45(1):63-70.
13. Jaruga B., Hong F., Sun R., Radaeva S., Gao B. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 2003, 171(6):3233-3244.
14. Hong F., Jaruga B., Kim W.H., Radaeva S., El-Assal O.N., Tian Z., et al. Opposing roles of Stat1 and Stat3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 2002, 110(10):1503-1513.
15. Ashkar S., Weber G.F., Panoutsakopoulou V., et al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000, 287(5454):860-864.
16. O'Regan A.W., Nau G.J., Chupp G.L., Berman J.S. Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today 2000, 21(10):475-478.
17. Xu G., Nie H., Li N., et al. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 2005, 115(4):1060-1067.
18. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 2007, 8(1):74-83.
19. Tanaka K., Morimoto J., Kon S., et al. Effect of osteopontin alleles on beta-glucan-induced granuloma formation in the mouse liver. Am J Pathol 2004, 164(2):567-575.
20. Morimoto J., Inobe M., Kimura C., et al. Osteopontin affects the persistence of beta-glucan-induced hepatic granuloma formation and tissue injury through two distinct mechanisms. Int Immunol 2004, 16(3):477-488.
21. Diao H., Kon S., Iwabuchi K., et al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 2004, 21(4):539-550.
22. Xu X.W., Lu M.H., Tan D.M. Association between tumour necrosis factor gene polymorphisms and the clinical types of patients with chronic hepatitis B virus infection. Clin Microbiol Infect 2005, 11(1):52-56.
23. Rittling S.R., Matsumoto H.N., McKee M.D., et al. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 1998, 13(7):1101-1111.
24. Nakae S., Komiyama Y., Nambu A., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17(3):375-387.
25. Teng C.B., Diao H.L., Ma X.H., Xu L.B., Yang Z.M. Differential expression and activation of Stat3 during mouse embryo implantation and decidualization. Mol Reprod Dev 2004, 69(1):1-10.
26. Lin Y.H., Yang-Yen H.F. The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J Biol Chem 2001, 276(49):46024-46030.
27. Fong Y.C., Liu S.C., Huang C.Y., et al. Osteopontin increases lung cancer cells migration via activation of the alphavbeta3 integrin/FAK/Akt and NF-kappaB-dependent pathway. Lung Cancer 2009, 64(3):263-270.
28. Chen Y.J., Wei Y.Y., Chen H.T., et al. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. J Cell Physiol 2009, 221(1):98-108.
29. Sun B.S., Dong Q.Z., Ye Q.H., et al. Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology 2008, 48(6):1834-1842.
30. Zhou W.L., Wu J.M., Wu Q.L., et al. A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo. Acta Pharmacol Sin 2005, 26(11):1352-1358.
31. Zhou Y.B., Ye R.G., Li Y.J., Xie C.M., Wu Y.H. Effect of anti-CD134L mAb and CTLA4Ig on ConA-induced proliferation, Th cytokine secretion, and anti-dsDNA antibody production in spleen cells from lupus-prone BXSB mice. Autoimmunity 2008, 41(5):395-404.
32. Diao H., Iwabuchi K., Li L., et al. Osteopontin regulates development and function of invariant natural killer T cells. Proc Natl Acad Sci USA 2008, 105(41):15884-15889.
33. Ramaiah S.K., Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci 2008, 103(1):4-13.
34. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992, 90(1):196-203.
35. Shinohara M.L., Kim J.H., Garcia V.A., Cantor H. Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. Immunity 2008, 29(1):68-78.
36. Wei L., Laurence A., Elias K.M., O'Shea J.J. IL-21 is produced by Th17 cells and drives IL-17 production in a Stat3-dependent manner. J Biol Chem 2007, 282(48):34605-34610.
37. Hue S., Ahern P., Buonocore S., Kullberg M.C., Cua D.J., McKenzie B.S., et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006, 203(11):2473-2483.
38. Wilson N.J., Boniface K., Chan J.R., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007, 8(9):950-957.
39. Tagawa Y., Sekikawa K., Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice. role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 1997, 159(3):1418-1428.
40. Tagawa Y., Matthys P., Heremans H., Dillen C., Zaman Z., Iwakura Y., et al. Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice. J Leukoc Biol 2000, 67(1):90-96.